Colgate-Palmolive (CL) Chief Growth Officer reports 156-share tax withholding

Rhea-AI Filing Summary

Colgate-Palmolive Company’s Chief Growth Officer reported a small share transaction involving company stock. On 12/03/2025, 156 shares of Colgate-Palmolive common stock were disposed of at $78.2 per share in a transaction coded “F,” which indicates shares were withheld by the company to cover Medicare and income tax obligations tied to previously granted restricted stock units. After this tax withholding, the officer beneficially owns 17,645 shares directly and 5,416 shares indirectly through the issuer’s 401(k) plan trustee. The underlying restricted stock units remain in place, reduced only by the shares used for required tax withholding.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hazlin John

(Last) (First) (Middle)

C/O COLGATE-PALMOLIVE COMPANY

300 PARK AVENUE

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COLGATE PALMOLIVE CO [ CL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Growth Officer

3. Date of Earliest Transaction (Month/Day/Year)
12/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/03/2025		F(1)		156	D	$78.2	17,645	D
Common Stock								5,416	I	By Issuer's 401(k) Plan Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Payment of Medicare and income tax liability by withholding shares of stock from restricted stock units previously granted under the issuer's incentive compensation plan. The reporting person continues to hold the restricted stock units originally granted, less the amount of this required tax withholding.

	/s/ Kristine Hutchinson, Attorney-in-Fact	12/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Colgate-Palmolive (CL) report in this filing?

The Chief Growth Officer reported an “F” code transaction on 12/03/2025, where 156 shares of Colgate-Palmolive common stock were withheld to pay Medicare and income tax liabilities tied to restricted stock units.

Was the Colgate-Palmolive (CL) insider transaction an open-market sale?

No. The filing explains that the shares were withheld from previously granted restricted stock units to cover tax obligations, rather than sold in an open-market transaction.

How many Colgate-Palmolive (CL) shares does the reporting officer own after the transaction?

Following the tax withholding, the officer beneficially owns 17,645 Colgate-Palmolive shares directly and 5,416 shares indirectly through the issuer’s 401(k) plan trustee.

What role does the reporting person hold at Colgate-Palmolive (CL)?

The reporting person is an officer of Colgate-Palmolive, serving as the company’s Chief Growth Officer.

What does transaction code "F" mean in this Colgate-Palmolive (CL) insider report?

Transaction code “F” indicates a payment of tax liability by having shares withheld from equity awards, in this case from restricted stock units granted under Colgate-Palmolive’s incentive compensation plan.

Did the Colgate-Palmolive (CL) officer keep the underlying restricted stock units?

Yes. The filing states the officer continues to hold the restricted stock units originally granted, reduced only by the portion used for the required tax withholding.